Patients with advanced synovial sarcomas:
Are younger and have a better performance status compared to other soft tissue sarcomas (STS) patients.
Have more often extremity tumours than other STS patients.
Show significantly better progression free survival and overall survival compared to other STS patients.
Have significantly better response to chemotherapy than other STS patients.